Life Sciences 2013 (August 2013)

Main

Introduction: The life sciences in 2013

The impact of first to file on life sciences in the US

Interview: Jurgen Dressel, Novartis on patent litigation strategy

US case analysis: Myriad at the Supreme Court

US Supreme Court rejects the ‘scope of the patent’ test

A guide to further medical use inventions at the EPO

How to ensure the safety of biosimilars in India

India: The implications for patent owners of section 3(d)

New criteria for pharmaceutical trade marks in Mexico

Editorial

Features / Articles

Sponsored